What's new in the field of prostate cancer chemoprevention?

Ian M Thompson, Kanwaljit Mahal, Javier Hernandez, Joseph W Basler

Journal: Current urology reports 2005;6(3):177-82

PMID: 15869721

Abstract

Chemoprevention trials for several malignancies are completed, planned, or underway. Prostate cancer is one of the most common forms of cancer and understandably has received considerable recent attention as a potential target for chemoprevention. This article examines chemoprevention trials for prostate cancer, including the Prostate Cancer Prevention Trial, Selenium and Vitamin E Cancer Prevention Trial, and cyclooxygenase inhibitors in the prevention of prostate cancer.

Address: Division of Urology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.

DOI: 10.1007/s11934-005-0005-6

Link outs

Free resources

Medical:

https://medlineplus.gov/prostatecancer.html

MeSH Terms: Antineoplastic Agents, Chemoprevention, Clinical Protocols, Cyclooxygenase Inhibitors, Humans, Male, Prostatic Neoplasms, Selenium, Vitamin E